Abstract
Several recent studies have created considerable confusion about the cause and prevention of kernicterus.1,2,3 In 1982, Levine et al1 demonstrated in rats that “kernicterus” could be produced by osmotic opening of the blood brain barrier. Using a technique described by Rapoport et al,4 a hypertonic solution of arabinose was infused into one carotid artery, producing a temporary osmotically induced disruption of the blood brain barrier in the ipsilateral hemisphere. Subsequent intravenous infusion of bilirubin resulted in yellow staining of the affected region. Levine proposed that movement of albumin bound bilirubin across a disrupted barrier was the principal cause of kernicterus, and presented this as “an alternative hypothesis” to the “free bilirubin theory.” However, he provided no evidence that the yellow staining produced brain damage, either by histological examination or behavioral consequences. These observations, together with other studies which failed to confirm any predictive indices for kernicterus in premature infants,2,3 prompted Lucey5 to editorialize that current concepts of the pathogenesis of kernicterus should be abandoned in search for a “more attractive hypothesis.”
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R. L. Levine, W. R. Fredericks, and S. I. Rapoport, Entry of bilirubin into the brain due to opening of the blood brain barrier, Pediatrics 69: 255 (1982).
D. A. Ritter, J. D. Kenny, J. Norton, and A. J Rudolph, A prospective study of free bilirubin and other risk factors in the development of kernicterus in premature infants, Pediatrics 69: 260 (1982).
S. B. Turkel, C. A. Miller, M. E. Guttenberg, D. R. Moynes, and J. E. Hodgman, A clinical pathologic reappraisal of kernicterus, Pediatrics 69: 267 (1982).
S. I. Rapoport, W. R. Fredericks, K. Ohno, et al, Quantitative aspects of reversible osmotic opening of the blood-brain barrier, Am J Physiol 238: R421 (1980).
J. F. Lucey, Bilirubin and brain damage - A real mess, Pediatrics 69: 381, (1982).
J. Jacobsen and R. P. Wennberg, Determination of unbound bilirubin in the serum of newborns, Clin Chem 20: 783 (1974).
W. B. Karp, Biochemical alterations in neonatal hyperbilirubinemia and bilirubin encephalopathy: a review, Pediatrics 64: 361 (1979).
R. P. Wennberg, C. E. Ahlfors, and L. F. Rasmussen, The pathochemistry of kernicterus, Early Human Develop 3 /4: 353 (1979).
W. M. Pardridge, Transport of protein-bound hormones into tissues in vivo, Endocrine Revs 2: 103 (1981).
H. Perl, A. Nijjar, H. Ebara, et al, Bilirubin toxicity without CNS staining, Pediatr Res 15: 303A, (1982).
R. P. Wennberg, The pathogenesis of kernicterus: factors influencing the distribution of bilirubin with albumin and tissue, in: “Metabolism and Chemistry of Bilirubin and Related Tetrapyrroles,”- A. F. Bakken and J. Fog, eds., Pediatric Research Institute, Oslo, Norway (1975).
M. Ahdab-Barmada, Neonatal kernicterus: Neuropathologic diagnosis, J Neuropath In press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wennberg, R.P., Hance, A.J., Jacobsen, J. (1984). The Importance of Serum Binding and the Blood Brain Barrier in the Development of Acute Bilirubin Neurotoxicity. In: Rubaltelli, F.F., Jori, G. (eds) Neonatal Jaundice. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7517-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7517-3_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7519-7
Online ISBN: 978-1-4684-7517-3
eBook Packages: Springer Book Archive